New Clozapine REMS: Staying Informed for the November 15 Changes-Presentation and Q&A

Video Transcription

Video Summary

Summary: The video discusses the new Clozapine REMS (Risk Evaluation and Mitigation Strategy) system, which is set to go live on November 15th. The video features Dr. Rob Cortez, Dr. Donna Rowland, and Dr. Megan Ehret as presenters, providing information for prescribers and pharmacists on the changes and requirements of the new system. The video covers topics such as recertification for prescribers and pharmacies, patient enrollment, the monthly patient status form, dispense authorizations for pharmacies, and workflow changes for both prescribers and pharmacists. The presenters also address concerns and questions from the audience, including issues related to designees, ANC lab reporting, and the use of fillable PDFs for submitting the patient status form. The presenters emphasize the importance of staying informed and ensuring compliance with the new system to ensure the safe and effective use of clozapine for patients. The video concludes with a reminder to claim credit for participating in the webinar and invites viewers to join the next webinar on peer-to-peer specialist relationships.

Keywords

Clozapine REMS

Risk Evaluation and Mitigation Strategy

November 15th

prescribers

pharmacists

recertification

patient enrollment

monthly patient status form

dispense authorizations

workflow changes